However, HO-1 also functions as a negative regulator in erastin- and sorafenib-induced hepatocellular carcinoma, since knockdown of HO-1 expression enhanced cell growth inhibition by erastin and sorafenib [66]. The gene discussed is HMOX1; the disease is hepatocellular carcinoma.